Literature DB >> 17885368

Diagnostic trinity: Graves' disease on F-18 FDG PET.

Yen-Kung Chen1, Yuh-Feng Wang, Jainn-Shiun Chiu.   

Abstract

A 31-year-old man underwent a whole-body F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) scan for cancer screening. There was no history of diabetes, thyroid disease, or noticeable exercise before imaging. The results demonstrated diffusely increased uptake of F-18 FDG in the thyroid and thymus. In addition, there was symmetrically increased uptake of F-18 FDG in skeletal muscles, especially in the psoas and limb muscles. The concurrent appearance of these characteristics led to a diagnosis of Graves' disease.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17885368     DOI： 10.1097/RLU.0b013e318148b47d

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  3 in total

1.  The effect of hypothyroidism on referential background metabolic activity on 18F-FDG PET/CT.

Authors:  Pei Yang; Qiuping Fan; Huawei Cai; Rong Tian; Minggang Su
Journal:  Quant Imaging Med Surg       Date:  2021-08

2.  Symmetric increased skeletal muscular uptake of F-18 fluoro-deoxyglucose: A clue for the diagnosis of Graves' disease.

Authors:  Sampath Santhosh; Bhagwant Rai Mittal; Raghava Kashyap; Anish Bhattacharya; Baljinder Singh
Journal:  Indian J Nucl Med       Date:  2011-07

3.  Diffusely increased thyroidal uptake of F-18 fluorodeoxyglucose in a patient with non-Hodgkin's lymphoma and Graves' disease.

Authors:  Koramadai Karuppuswamy Kamaleshwaran; Raghav Kashyap; Chidambaram Natarajan Balasubramaniam Harisankar; Anish Bhattacharya; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2012-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.